Used in pharmaceutical research as a key intermediate in the synthesis of histone deacetylase (HDAC) inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification of enzyme activity involved in gene expression and cell proliferation. Also explored in prodrug design due to its ability to release active phenolic compounds upon enzymatic cleavage. Shows potential in targeted therapies where controlled drug activation is required.